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CHARACTERIZING THE VIRULENCE FACTOR YAPE IN YERSINIA PESTIS 
Tiva T. VanCleave 
April 25, 2018 
 
Yersinia pestis is the causative agent of bubonic plague and is primarily 
transmitted by fleas. Upon infection, the bacteria rapidly travel to the regional 
lymph nodes causing inflammation and cellulitis in these tissues (referred to as 
buboes). Two outer membrane proteins, YapE and Pla, have been implicated to 
have roles in dissemination to the lymph nodes. Their adhesive properties have 
shown that they are able to interact with host macrophages thereby increasing 
their ability to disseminate to regional lymph nodes. More recently, we have 
shown that YapE is cleaved by another virulence factor important for lymph node 
colonization, Pla, to become an active adhesin. To further understand the biology 
of YapE, I used a transposon mutagenesis screen to identify possible regulators. 
While the current approach did not identify novel regulators, I discuss potential 
modifications to screening conditions that may allow for increased success in 
future attempts. I also investigated the role that Pla may play in the activation or 
degradation of other outer membrane proteins. 2-DIGE analysis identified 76 Y. 
pestis proteins that may be processed by Pla and I confirmed Pla-dependent
vii 
 degradation on HmsF at 37°C. To further investigate the role outer membrane 
proteins may play in intracellular survival, I infected macrophages with Y. pestis 
strains lacking pla, yapE, ail or ompA. Before performing these intracellular 
assays, I developed an optimized gentamicin protection assay to monitor 
intracellular growth of Y. pestis. To this end, I determined that the concentration 
of gentamicin used for Y. pestis should not exceed 8 µg/ml for 1 hour. Using this 
assay, I verified that OmpA was required for Y. pestis intracellular survival in 
macrophages. While Y. pestis lacking Pla or YapE had minor defects in 
intracellular growth, an ail mutant showed no phenotype difference compared to 
WT. Future studies with mutants lacking  multiple  adhesins will help to define the 
potential contributions of these proteins to intracellular survival.
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YERSINIA PESTIS AND PLAGUE
2 
Plague is an enzootic disease that has caused three pandemics worldwide [1].  
These pandemics consisted of the Justinian plague (541 AD), The Black death 
(1334 AD) and the current, Modern plague (1900 AD). The current pandemic, 
Modern plague, came by way of infected rats that travelled on steamships from 
Asia and spread among port cities around the world. This pandemic came to the 
western shores of the United States, and can still be found in western states such 
as New Mexico, Arizona, Colorado, California, Oregon, and Nevada 
(https://www.cdc.gov/plague/maps/index.html). In the United States animals such 
as rock squirrels, wood rats, ground squirrels, prairie dogs, chipmunks, mice, 
voles, and rabbits can be affected by plague (CDC and 
https://emedicine.medscape.com/article/235627-overview#a6). Plague still 
remains a significant concern for public health because of its ability to be 
transmitted person to person through respiratory droplets and possible use in 
bioterrorism and biological warfare [2, 3].  Currently, Y. pestis is listed as a Tier 1 
Category A Select Agent due to its potential to be used as a weapon [3, 4]. 
From 1970-2016 there have been between 1-17 cases per year reported in the 
United States (https://www.cdc.gov/plague/maps/index.html). Outside of the 
United States, plague is much more prevalent, especially in Africa and Asia. 
Currently, the Center for Disease Control (CDC) and the World Health 
Organization report that as recent as August 1 – November 22, 2017 that in 
Madagascar alone there were a total of 2348 confirmed cases of plague with a 
fatality rate 8.6% (http://www.who.int/csr/don/27-november-2017-plague-
madagascar/en/).  
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Plague is caused by the Gram negative bacterial pathogen Yersinia pestis [5]. 
When transmitted by fleas, the bacteria initially colonizes the intradermal space 
before migrating to the draining lymph node, where it causes inflammation and 
cellulitis resulting in a bubo (bubonic plague) [6].  Left untreated, the bacteria can 
escape from the lymph node and disseminate systemically through the blood to 
various organs causing a fatal sepsis known as septicemic plague. Secondary 
pneumonic plague occurs during the septicemic infection when the blood 
circulating with the bacteria goes to the lungs.  A primary pneumonic infection can 
also occur by direct inhalation of infectious droplets or aerosols and develops into 
acute pneumonia, intra-alveolar hemorrhage and edema, profound lobular 
exudation, fibrin deposition, and bacillary aggregation [2, 7].  Due to acute and 
systemic infections, the mortality rate of plague reaches 70-100% without 
treatment depending on routes of infection [8].  
Y. pestis virulence determinants 
Y. pestis belongs to the family Enterobacteriaceae where Yersiniae contains 14 
species, with three being pathogenic to humans [9-11]. Two are enteric pathogens, 
Y. entercolitica and Y. pseudotuberculosis and the third, Y. pestis, is the agent of 
plague. Y. pestis diverged from Y. pseudotuberculosis approximately 1,500-
20,000 years ago [12, 13]. During this divergence, Y. pestis acquired two additional 
plasmids (pPCP1 and pMT1) that are necessary for transmission of the bacteria 
from the flea vector to the mammalian host [5, 12, 13]. Furthermore, Y. pestis has 
also acquired new virulence factors and lost genes that are required for enteric 
infection but not for plague [5]. 
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1. Evasion of the immune response by the Ysc Type III Secretion System 
(T3SS) 
The T3SS is found on the pCD1 plasmid, which is present in all three 
pathogenic species of Yersinia [5]. The assembly of the T3SS allows for 
transport of effector proteins across the inner and outer bacterial membranes 
of the bacterium in addition to across eukaryotic membranes [14]. These 
effector proteins released through the T3SS are referred to as Yops (Yersinia 
outer membrane proteins). The Yops allow for disruption of the cytoskeleton, 
mediate cell adhesion, and facilitate the adherence of the T3SS for Yop 
injections [14, 15]. In vivo, Y. pestis injects their effector Yops targeting 
primarily neutrophils but also phagocytes such as macrophages and dendritic 
cells although in vitro, they are able of injecting effector Yops into essentially 
any cell [16]. The T3SS is expressed when inside a mammalian host (37°C) 
and has no role in the colonization of the flea (26°C) [5]. 
There are seven Yops found in all three Yersinia spp.; YpkA/YopO, YopH, 
YopE, YopJ/YopP, YopK, YopM, in addition to YopT that is only found in Y. 
entercolitica. YpkA/YopO, YopE, YopT and YopH play a role in the disruption 
of the actin cytoskeleton and target eukaryotic cell signaling components of the 
RhoA family of small GTPases that facilitates the inhibition of phagocytosis 
with the exception of YopH for the later [17, 18]. Additionally, YopH disrupts 
both the innate and adaptive immunity pathways that are important for the 
virulence of all three pathogenic species in mice [17, 19], in addition to 
inhibiting autophagy and blocking phagocytosis in macrophages [17, 20, 21]. 
5 
YopP/J inhibit the ability to activate and release NF-Kβ, keeping the cell in an 
anti-inflammatory state [22-26]. YopJ also has been shown to inhibit caspase-1 
in activated macrophages [27]. YopM is essential for Yersinia virulence 
because of its capacity to downregulate proinflammatory responses while 
upregulating IL-10, an anti-inflammatory cytokine [28-31]. Comparable to YopJ, 
YopM has been shown to block mature caspase-1 activity inhibiting the 
recruitment of pro-caspase-1 to the inflammasome complex [32-34].  Loss of 
the T3SS or the pCD1 plasmid results in complete attenuation of all three 
pathogenic species in mice [18]. This further validates the importance that the 
T3SS is vital for the virulence of the bacteria.  
2. Modulation of LPS 
One way that Y. pestis is able to avoid immediate clearance from the host once 
infection has begun is to be able to sense the change in environment, and 
change the conformation of its LPS when going from the flea to the mammalian 
host. At 26°C (flea), the LPS is hexa-acylated which is recognized by TLR-4, 
inducing proinflammatory cytokines such as IL-8, IL-1 and TNF. During a 
temperature shift, that happens during infection into a mammalian host (37°C), 
the LPS changes to the tetra-acylated form that does not stimulate TLR-4 and is 
an antagonist for hexa-acylated LPS [35, 36]. To further validate the role the 
change in LPS has on virulence, Montminy and co-workers altered the LPS of Y. 
pestis to be a more powerful TLR-4 stimulant. The change to the stimulatory 
form of LPS caused Y.pestis to be rendered completely avirulent after 
subcutaneous infection [36].   
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3. Iron uptake 
Siderophore-based iron acquisition has been seen as a hallmark for virulence in 
successful pathogenic bacteria [37]. This is true for the pathogenicity of 
Yersiniae and its ability to acquire iron. All three pathogenic species of Yersinia 
use the siderophore Yersiniabactin (Ybt) [37].  The iron accumulated from the 
host allows for metabolic stability for the purpose of multiplying to cause systemic 
infections [38]. Yersiniabactin synthesis in Y.pestis consists of irp1 and 2 and 
ybtU,T,E and S, and are clustered on a mobile genetic element known as the 
High Pathogenicity Island that makes it possible to be widely disseminated in 
Enterobacteriacea [37]. This siderophore plays an important role in the 
acquisition of iron and murine virulence [37, 39, 40]. Inactivation of Ybt has been 
shown to significantly attenuate Yersinia [37, 39, 41-45].  
4. Plasminogen activation by Pla 
Pla is encoded on the plasmid pPCP1. pla was identified as one of the most 
exceedingly expressed genes in Y. pestis isolated from bubos of infected rats 
[46, 47]. Pla is a member of the omptin family of proteases that has evolved 
specifically for bubonic and pneumonic forms of plague [48]. Pla is able to 
convert plasminogen to plasmin allowing for the degradation of extracellular 
matrices permitting Y. pestis to quickly invade the host and migrate to draining 
lymph nodes [17, 49-51]. During subdermal or subcutaneous infection, Y. pestis 
expressing Pla had wide-spread bacterial foci with minimal recruitment of 
inflammatory cells [48, 52]. Conversely, when Pla was not expressed, it resulted 
in an accumulation of bacteria at site of infection, causing an inability to 
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disseminate and thereby increasing the recruitment of immune cells [48]. Unlike 
the bubonic (subcutaneous) model, Pla is not necessary for the dissemination 
from the initial site of infection for primary pneumonic plague. Pla is pivotal for the 
progression of primary pneumonic plague by assisting in the growth or survival 
and proliferation of Y. pestis in the lungs [46, 53]. Pla is important for the fitness 
of the bacteria for both bubonic and pneumonic plague although through differing 
mechanisms. This shows the multifaceted nature of Pla, that while it is 
dispensable for the spread of Y. pestis in pneumonic plague, its protease activity 
is important during bubonic plague.  
5. The Capsular antigen fraction 1 (Caf1) Capsule 
The Caf1 capsule is made up of the Fraction 1 (F1) antigen, a fimbrial protein 
that accrues on the bacterial surface to form a capsule unique to Y. pestis [54]. 
Caf1 capsule is strongly influenced by temperature, where essentially no 
capsule is identified in the flea vector or at temperatures <35°C [54]. The caf1 
gene is the most highly expressed genes during infection of the mammal, 
indicating that it is a virulence factor [54]. Studies have shown that the capsule 
works in tandem with the T3SS to make Y. pestis resistant to uptake by 
macrophages and PMNs [55-58]. Although the caf1 gene is highly expressed, 
there has been conflicting data on its requirement for virulence [56, 59]. Some 
studies with bubonic plague in mice and guinea pigs, and pneumonic plague in 
primates, have shown that when the F1 capsule is not present, there is no effect 
on virulence [56, 60, 61]. Conversely, Gonzalez and co-workers were able to 
show that in C57BL/6J mice a Δcaf1ΔpsaA strain had a significant attenuation in 
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dissemination or colonization into deeper tissues from the lymph node compared 
to the WT Y. pestis [59]. However, the same Δcaf1ΔpsaA strain was not 
attenuated in BALB/cJ mice [62]. The previous findings by Weening and co-
workers showed that differences in virulence with caf1 was predicated on the 
mouse background [62]. Although there appears to be evidence that the capsule 
plays a minor role in virulence, depending upon host; it has been shown that 
minute amounts of the F1 subunits and the outer membrane Caf1A protein have 
an affinity to the IL-1 receptor on macrophages and to IL-1β expression by 
epithelial cells [63-65]. This may play a role in early infection by conferring 
adhesion or anti-immunity potential [54]. 
6. Y. pestis Adhesins 
The ability to target cells for T3SS has been directly linked to bacterial adhesins 
[66]. In the enteropathogenic Yersiniae, two important adhesins, YadA and 
Invasin, facilitate bacterial attachment and Yop injection [14, 15].  Although 
these two adhesins are important for the pathogenicity of Y. entercolitica and Y. 
pseudotuberculosis, yadA and inv are pseudogenes and not expressed in Y. 
pestis [17]. Therefore, other adhesins, have taken on the roles of YadA and Inv.   
Ail   
Ail functions as a multi-factorial adhesin in Yersiniae [17]. During its divergence 
from the two enteric pathogens, it gained additional roles in the virulence of Y. 
pestis that include; 1) facilitating the injection of Yops into host cells [14, 67], 2) 
inhibition of the inflammatory response [68], 3) inhibition of the bactericidal 
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properties of complement [68-70]and 4) prevention of neutrophil recruitment to 
the lymph nodes [69, 70]. Ail has been shown to be the primary adhesin in the 
attachment of the T3SS to host cells in Y. pestis where its deletion exhibits 
significant reduction in binding to epithelial and monocytic cells [17, 70]. 
Interestingly, the transcription of Ail can also be altered when other outer 
membrane components are mutated [70]. In addition when comparative 
proteome strategies were used to identify new virulence targets found that Ail 
clustered together with virulence associated proteins on the plasmid pCD1. 
Pla 
In addition to being a protease, Pla also has adhesive properties [71]. It has been 
linked to invasion of host immune cells and dissemination by its interaction with 
CD205 on macrophages [72]. A pla mutant is attenuated in a mammalian host 
due to both its inability to disseminate from the site of infection and through its 
uptake by macrophages. In addition to attachment to phagocytes, Pla is also 
necessary for the positioning of the T3SS for the delivery of Yops [71].  
YadB/C 
YadB and YadC have the ability to form oligomers that lead to aggregation and 
mediate invasion to epithelial cells, although they are not necessary for host cell 
adherence [72, 73]. Studies have shown that when both proteins are mutated, 
there is a substantial decrease in the ability for the bacteria to invade HeLa cells 




Autotransporters are found in Gram-negative bacteria and are comprised of a N-
terminal signal sequence, passenger domain, and C-terminal β-domain. Within the 
Yersiniae species there are nine Yersinia autotransporter proteins (Yaps) that 
produce functional proteins [74]. Autotransporters can contribute to pathogenesis 
through adherence to eukaryotic cells, proteolysis, complement resistance and 
cytotoxicity [75]. One particular autotransporter that has been conserved in all 
three pathogenic species is YapE. 
YapE 
YapE has been maintained in all the pathogenic species of Yersiniae [76]. The 
conservation of yapE in Yersinia suggests that YapE may be a virulence factor. 
YapE is capable of facilitating contact between bacteria and eukaryotic cells 
through its adhesive properties [76]. YapE also promotes adherence to 
eukaryotic cells. This was demonstrated by Lawrenz and co-workers with the 
evaluation of the adherence of bacteria to RAW264.7 macrophage cells. They 
found that the expression of native YapE in Y. pestis had a significant increase of 
adherent bacteria (3.5 fold increase, P<0.0001).  
YapE also allows for of aggregation in Y. pestis and Y. pseudotuberculosis but 
not in its distant relative, Y. entercolitica when expressed in E.coli [76]. A study by 
Lawrenz and co-workers showed that the processing of YapE by the omptin, Pla, 
is specific to Y.pestis but not its enteric predecessors [77].  The post-translational 
modification of YapE appears to have been acquired after Y. pestis diverged 
11 
from Y.pseudotuberculosis and Y. entercolitica [77]. As well as allowing for 
bacterial aggregation, this processing was also shown to be necessary for the 
adhesion to eukaryotic cells [76]. Their data showed that processing by Pla is 
necessary for YapE to play a role in bacterial aggregation and eukaryotic cell 
adhesion.  
7. Role of intracellular survival 
Y. pestis is considered a facultative intracellular pathogen due to its ability to 
replicate in macrophages and neutrophils [5, 78, 79]. During a subcutaneous 
infection (bubonic), there is a robust innate immune response with an immediate 
arrival of both neutrophils and macrophages.  However, initial neutrophil killing of 
the bacteria is greater because the bacteria has not had an opportunity to employ 
many of its anti-phagocytic properties during the transitional phase from the flea 
to a mammalian host. Following infection with Y. pestis, neutrophils are rapidly 
employed to the site and phagocytose the bacteria. Macrophages also engulf the 
bacteria, although to a lesser degree, and appear to move away from the site of 
infection [80].  It has been shown that although neutrophils have a high success 
rate of eliminating Y. pestis, a small number of Y. pestis is still able to replicate 
inside the hostile environment [78]. Due to the attenuated lifespan of neutrophils, 
dying neutrophils are cleaned up by resident macrophages. Once the bacteria is 
taken up by the macrophage, it is housed in a Yersinia containing vacuole (YCV) 
where it is able to subvert the phagolysosomal degradation pathway [81]. The 
intracellular lifecycle of Y.pestis has been shown to be important for virulence. 
This has been exhibited by lower bacterial burden when animals were depleted 
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for dendritic/macrophage populations during plague infection and survival defect, 
in macrophages, by a phoPQ mutant [30, 80, 82-85]. 
Central hypothesis and Aims 
YapE mediates interactions with macrophages and is required for disseminated 
disease. Therefore, my central hypothesis is that YapE-dependent interactions 
with macrophages contribute to overall virulence of Y. pestis. The following aims 
were designed to further understand the biology associated with YapE. 
Aim 1:  Identify genetic regulators of yapE in Y. pestis. 
Aim 2: Determine if other outer membrane proteins are processed by Pla. 





IDENTIFICATION OF REGULATORS OF YAPE
14 
Introduction  
Bacteria regulate the expression of genes in response to the environment in 
order to survive in specific niches. Virulence determinants are tightly and 
coordinately regulated during infection. Virulence-related regulators can sense 
host signals (e.g., changes in temperature) and then differentially regulate large 
sets of genes required for adaptation to the host niche [86]. In the case of 
pathogens, virulence genes are regulated in a coordinated fashion to allow the 
bacterium to infect its host. Y. pestis is maintained in an enzootic cycle between 
mammalian and insect hosts [87] and several studies have shown tight regulation 
of virulence factors in Y. pestis dependent on host [74, 88, 89].  
yapE transcription levels are very low during in vitro growth [74]. To evaluate in 
vivo transcription, Lenz and co-workers used both a bubonic and pneumonic 
plague model, and compared transcription levels of yapE, yapG and yapC grown 
at 26° in broth cultures [74]. They observed a significant increase in yapE 
expression in vivo compared to in vitro.  Following subcutaneous infection, yapE 
transcript increased 15-fold increase in expression of yapE in cervical lymph nodes 
by 72 h and an approximate 5-fold in the lungs during pneumonic plague [74]. This 
increase of expression in vivo, for both the pneumonic and bubonic models, 
suggest that YapE may be important for mammalian infection [6]. In addition to 
observing the differing levels of transcription in both models. Differences in levels 
of yapE expression between the lymph nodes and lungs may suggest that yapE 
has a more substantial role in bubonic infection than pneumonic infection. This 
was confirmed when using a bubonic mouse model (subcutaneous) and 
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challenging with a yapE mutant and parental WT (CO92) strain. Colonization of 
proximal lymph nodes had a noticeable delay in colonization compared to WT by 
36 hours post infection. When the same challenge was performed on a pneumonic 
plague model (intranasal), the mutated yapE strain did not significantly alter the 
ability for the lungs to be colonized [76].  
To further understand what stimuli is responsible for the change of expression 
between the in vivo and in vitro testing, the bacteria were subjected to varying 
stimuli such as temperature, iron, calcium, and pH in vitro [74]. None of these 
environmental ques changed the expression of yapE in vitro [74]. To this end, it 
was surmised that there must be other signals in vivo, that allows the bacteria to 
streamline gene expression.  
These findings support the hypothesis that yapE transcription is regulated in Y. 
pestis. Here I attempted to elucidate the regulatory mechanisms for yapE 
expression. Defining these mechanisms will help us to better understand how Y. 
pestis regulates gene expression in response to host colonization.  
Materials and methods 
Construction of the yapE reporter in Y. pestis CO92 pCD1-∆lacZ∆yapE 
background  
The bacterial strains and plasmids utilized in this study are listed in Table X. Y. 
pestis was grown in Brain Heart Infusion (BHI) broth at 26°C. Antibiotics were used 
at the following concentration: chloramphenicol, 12.5 µg/ml (Yersinia). 
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The promoter regions upstream from the yapE gene were amplified by PCR with 
primers DNA278 (5’ – GG GGT ACC C TGG CTA TCA TTG TTT TAC GAA AGC 
– 3’) and DNA368 (5’ – G GGA TCC CTT ATG GCT TGC TGA TAA TAG CAG 
AGT – 3’). The resulting product was gel purified and digested with KpnI and 
BamHI. The resulting fragment was ligated onto pFU99 and transformed into 
YPA109 to generate YPA111.  
Transposon Mutagenesis 
YPA111 was grown in BHI broth at 26°C in chloramphenicol 12.5 µg/ml and E. 
coli (S17) containing the transposon pAJD428 (LOU117) was grown in Luria-
Bertani (LB) broth at 37°C in Kanamycin 50 µg/ml. In a separate tube, a 3:1 
(LOU117:YPA111) was added to sterile 10 mM MgSO4. The mixture was then 
placed into the 3 cc syringe attached to a Swiznet filter containing a membrane 
filter (0.45 um HV) allowing the solution to be pushed through the membrane 
filter. Using flame sterilized tweezers, the membrane was removed from the filter 
and placed on a BHI agar plate that has no antibiotic and allowed the bacteria to 
grow overnight at 26°C. The following day the membrane was removed from the 
agar plate and placed into a 1.5 ml tube with 1X sterile PBS and vortexed for 45 
seconds. The bacteria was then plated the rehydrated bacteria (straight) onto 
BHI agar plates containing; Kanamycin 100 µg/ml, Chloramphenicol 12.5 µg/ml, 
Polymyxin 25 µg/ml, X-gal80 µg/ml and IPTG 1mM and allowed to grow for 2 





Blue colonies that developed on the mating plate were isolated and grown in BHI 
broth overnight. The following day 1.5 mls of the bacteria were pelleted by 
centrifugation and re-suspended in a buffer of 50mM Tris and 50 mM EDTA. 
10%SDS and Pronase were added to the re-suspended bacteria and allowed to 
incubate for 1 hour at 42°C until the solution was clear. Phenol was added and 
the mixture was shaken for one hour. To the mixture, chloroform was added and 
centrifuged for 15 minutes at 7,000 x g. The top phase was transferred into a 
clean 1.5 ml Eppendorf tube and 3M of sodium acetate (NaOAc) and 95% 
ethanol was added and inverted allowing the DNA to precipitate out of solution 
and the DNA was rinsed with cold ethanol. To the rinsed DNA, TE and RNase 
was added and allowed to incubate at 37OC for 1 hr allowing the DNA to unwind 
into solution. After incubation, sodium acetate and cold isopropyl alcohol is 
added to the solution containing the DNA and centrifuged for 10’ @ 13,000 RPM. 
The remaining pellet was washed 2 x with 70% EtOH and the DNA was allowed 
to dry for 30 minutes at room temperature. The dried pellet was then re-suspend 
DNA 200 in µl H2O for further evaluation.  
 
Arbitrary PCR 
To identify the insertion site of the transposon from the isolated DNA above, we 
performed two rounds of PCR with the first round amplifying the junction between 
the TnMod-RKm’-laclq-tacp (pAJD428) and the Y. pestis chromosome using 5’-
GGC CAC GCG TCG ACT AGT ACN NNN NNN NNN ACG CC-3' (DNA457) and 
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5'-GAC AAT TAA TCA TCG GCT CG-3'  (DNA458). The PCR was ran on an 0.8% 
agarose gel and then the PCR product was then purified using the Promega PCR 
clean up kit and eluted in ddH2O. The purified PCR product was then amplified for 
the transposon using primers 5'-GGC CAC GCG TCG ACT AGT AC-3'  (DNA459) 
and 5'-TCG GCT CGT ATA ATG TGT GG-3' (DNA460). Again, the PCR was ran 
on a 0.8% agarose gel for verification. The resulting PCR was then then purified 
using the Promega PCR clean up kit and eluted in ddH2O and sent for sequencing 
using M13 reverse primer  5'-AGC GGA TAAC AAT TTC ACA CAG GA-3'   
(DNA461). When the results were returned, the inverted repeats were identified 
(TGAACACATATTCTCAGTC) and the sequence upstream of the inverted repeats 
were placed in NCBI BLAST to identify the region of insertion in the Y.pestis 
chromosome.  
 
Construction of the inducible phage construct 
The genetic regions YPO2277-2281 were amplified using 5'- CGC ACT GAC CCA 
ATT CGA GCA GAA CAG AAG CGC C -3' (DNA567) and 5'- TTC GAT ATC AAG 
CTT ATC GAT ACC GTC GAC TCA CCA ATC AGG CCT -3'(DNA581) and the 
inducible plasmid, pMWO-034 was amplified using 5'- GGC GCT TCT GTT CTG 
CTC GAA TTG GGT CAG TGC G -3' (DNA570) and 5'- AGG CCT GAT TGG TGA 
GTC GAC GGT ATC GAT AAG CTT GAT ATC GAA -3' (DNA580). The PCRed 
vector, pMWO-034, was digested with DpnI and incubated at 37 for 1 hour. Gibson 
cloning was performed by adding the amplified phage region (YPO2277-2281) to 
the vector and incubated at 50° for 1 hour and placed on ice. The assembled 
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reaction was dialyzed for 20 minutes and electroporated into DH5α cells and 
recovered in room temperature LB broth. The electroporated DH5α cells were 
incubated on the roller drum for 1 hour at 37°C. The reaction was then plated onto 
LB/Kan50 plates and placed in the 37°C overnight. 
Confirmation of phage insertion into pMWO-034 plasmid 
Clones from the assembled Gibson cloning of the phage region (YPO2277-2281) 
were grown in LB broth overnight at 37°C and the plasmids were extracted using 
the Wizard® Plus SV Minipreps DNA Purification System. The plasmids were then 
subjected to restriction digest with BamHI for 3 hours and then ran on an 0.8% 
agarose gel to confirm insertion.  
Miller Assay for induction of phage in high salinity and high osmolarity 
Bacterial strain YPA111 was grown in BHI at 26°C overnight and diluted 1:12.5 
into 5 mls of M9 media and allowed to grow for 1 hour at 26°C.  After the first 
hour, 1 mM IPTG was added to the media containing the phage containing strain 
YR076 and placed on the roller drum to incubate for 2 hours at 26°C (T=3h). To 
the respective sample, to test for stress induced by salinity, 5M NaCl was added 
to the media for a final concentration of 0.5M NaCl for high salinity; the bacteria 
experiencing high osmolarity sorbitol was added to the culture for a final 
concentration of 0.5M sorbitol for 20 minutes. OD600 readings were taken after 20 
minutes of growth for all samples NaCl, sorbitol and both controls. Assay tubes 
were set up to include the Z buffer containing 60 mM disodium phosphate, 40 
mM monosodium phosphate, 10 mM potassium chloride and 10 mM magnesium 
sulfate and β-mercaptoethanol. To the buffer, chloroform and 0.1% SDS was 
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added. Cells were added to working buffer and lysed immediately by vortexing 
for 10 seconds. The samples were allowed to incubate at room temperature for 5 
minutes.  
The β-galactisidase reaction began by adding ONPG as well as the timer to 
begin the reaction and quickly vortexed. After sufficient color change, the 
reaction was completed by adding Na2CO3 and the stop time was recorded. The 
sample was quickly vortexed and allowed to sit for 5-10 minutes allowing the 
particulates settle. Once the reactions were completed, the top layer was 
transferred into a cuvette, and the absorbance was measure at OD420 and OD550. 
1. Determine Miller Units using the following formula: 
Miller Units = 1000 x [(OD420 - 1.75 x OD550)] / (T x V x OD600) 
 OD420 and OD550 are read from the reaction mixture. 
 OD600 reflects cell density when harvested. 
 T = time of the reaction in minutes. 
 V = volume of culture used in the assay in mLs. 
  
Results: 
Transposon mutagenesis screen 
To identify gene(s) that are involved in the regulation of yapE, we designed a 
reporter system where we fused the promoter region of yapE to a lacZ gene that 
gives a colormetric readout when the transposon inserts itself into gene(s) that 
may influence yapE regulation (Fig. 2-1). Using this reporter strain, a transposon 
library was generated, using the Tn5 pAJD428 transposon. The pAJD428 
transposon is different from the traditional Tn5 transposon that it also contains an 
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outward facing lac promoter. This allows for the observation of both positive and 
negative regulators. The limitation of the Tn5 is that the only regulator that can be 
screened is a negative regulator. The pAJD428 transposon, because of the 
outward facing lac promoter, is able to also screen positive regulators. This can be 
observed when plated in the presence of IPTG that will drive the lac promoter 
allowing continued transcription of the gene in which the transposon inserted. Over 
54,000 colonies were screened using the pAJD428 with 100 containing the blue 
phenotype indicating increased expression of yapE.  
To determine if the transposon inserted itself into a positive or negative regulator 
of yapE, I grew each blue colony in the presence or absence of 1 M IPTG. Colonies 
that turned white in the absence of IPTG, were designated IPTG dependent, 
suggesting transposon insertion upstream of a positive regulator. Those that 
remained blue in the absence of IPTG were designated IPTG independent, 
suggesting insertions into negative regulators (Table 2-2). Of the 100 original 
colonies 36 were IPTG dependent. 
Identification of transposon insertions 
Genomic DNA was isolated from each clone and arbitrary PCR was performed to 
identify the genomic area where the transposon inserted. 22 were found in sugar 
transport and metabolizing genes, 56 were inserted into the reporter plasmid, 1 
into an E.coli DNA polymerase II, and 1 into a phage-related membrane protein. I 
was not able to identify insertion sites for 20. Due to the nature of the screen, the 
sugar transport and metabolizing genes were not further investigated because they 
fell into an operon containing lacI and a putative galactosidase gene (Table 2-1). 
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Since the readout is from cleavage of X-gal by β-galactasidase it was determined 
that these may be false positive.   
Identification of Phage insertion 
From the 100 colonies that were isolated, one insertion, that was IPTG 
independent, was in a phage related membrane protein (Table 2-1). During the 
screen there were instances where there was a secondary insertion one in the 
reporter plasmid and one in the secondary region. To ensure there was no 
secondary insertion causing the change in yapE expression, plasmid isolated from 
the clone containing the phage insertion (YR076), the vector plasmid, and a 
sample that had a known insertion into the plasmid (YR100) were cut by restriction 
digest to linearize the plasmid and compare the sizes (Figure 2-3). An increase in 
size would denote an insertion of the transposon in the reporter plasmid. To this 
end, it was verified that there were no additional insertions in the reporter plasmid.  
 
Determining if insertion in the Phage-like protein influences yapE expression.   
To determine if the transcription of the phage shock protein is regulating yapE, an 
inducible phage was designed consisting of the phage-like and secretion proteins 
sequence and the two hypothetical proteins flanking that region.  The transposon 
inserted itself between YPO2278 and YPO2279 and I wanted to include the genes 
upstream and downstream of the insertion site (Fig.2-5).  
The genomic region used for the inducible plasmid codes for the filamentous 
phage, YpfΦ. We first wanted to determine if induction of this phage would alter 
the growth of the bacteria. To determine if there was a growth defect, OD600 
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readings were taken every 2 hours for 8 hours of YR076 (induced with IPTG and 
uninduced), vector containing strain (YPA111) and WT (YPA035). Induction of 
YR076 was performed after 1 hour of initial growth. Over the first 6 hours there 
was no difference between ODs of each of the samples. By hour 8, there was a 
slight decrease in OD in both the induced and uninduced YR076 although it was 
shown to be statistically insignificant (Fig. 2-4). Since there was no change in 
growth when the phage protein was expressed by the YR076 clone, I decided to 
perform a β-galactosidase assays placing the YapE reporter strain (YPA111) in 
stress conditions to activate the native phage.  
Phages are activated under stressful conditions and produce a protein termed 
phage shock protein (psp). The phage shock protein response is well 
characterized in Y. pestis predecessor, Y. entercolitica. These proteins are 
required for regulation and stress tolerance [90]. Lenz and co-workers have 
previously shown that when Y. pestis is placed under environmental stressors, 
there was an influence in the expression of several Yaps (Table 2-2). Although, 
there was no change in vitro when placed under these stressors, there was an 
increase in vivo of yapE at 37°C. Three stressors that were not evaluated in the 
Lenz screen were, low Mg2+ concentration, osmolality and salinity. To determine if 
one of the aforementioned stressors may have some influence on the phage 
transcription, I decided to perform a Miller assay (β-galactosidase assay) using the 
yapE reporter strain (YPA111).  Compared to the control, YR076, there was no 
change in expression of the yapE promoter region for any of the three stressors 
(Fig 2-7 and 2-8).    
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Because I was unable to activate the native phage, the inducible phage protein 
plasmid that was constructed was tested next. By Western blot analysis, the 
inducible plasmid containing strain (YPA131) was compared to an inducible strain 
of CO92 containing a yapE overexpression plasmid (YPA024). Because 
endogenous YapE is so low in vitro, the use of an overexpressing strain for yapE 
allows for verification of YapE in addition to having the ability to quantify the overall 
amount of protein produced. The both samples (YPA131 and YPA024) were 
induced with anhydrous tetracycline (aTc) or no anhydrous tetracycline were 
added to the samples (negative control). Samples were acquired every 2 hours for 
6 hours and the Western blot membrane was probed with 1:1000 α-yapE. 
Compared to the overexpression YapE strain, there was no visible detection of 
YapE at any of the time points from the samples containing the inducible phage 
(Fig. 2-6). As stated earlier, previous studies by Lenz and Lawrenz, YapE 
expression is low in vitro and an overexpression plasmid was required to observe 
YapE by Western blot. Another possibility for a negative blot is that the amount of 
YapE expressed may be below the limit of detection by Western blot analysis.  
Discussion 
Initially, I previously screened over 15,000 clones using a Tn5 transposon and 
acquired 75 clones containing the blue phenotype. The initial use of the Tn5 
limited the scope of identifying regulators because the only regulators that could 
be identified were negative regulators. To increase the scope of the screen, I 
changed to the pAJD428 transposon. Much like the Tn5, pAJD428 consists of 
inverted repeats and a kanamycin cassette but it also contained an outward 
25 
facing inducible lac promoter. If the transposon inserted itself into a negative 
regulator, thereby inactivating the repressor, would allow for increased activity of 
yapE promoter. This allowed for the observation of both negative and positive 
regulators by way of dependence or independence of IPTG. To this end, I was 
able to perform a >10-fold coverage screen of the Y. pestis genome, screening 
54,931 colonies for changes in yapE expression using the pAJD428 transposon.  
YapE is a highly conserved autotransporter and has been shown to be a 
virulence factor due to its increased upregulation in vivo at 37°C, ability to 
adheres to RAW macrophages by 3.5-fold, and displays a delay in dissemination 
and colonization of the lymph nodes [76].  Because bacteria coordinate 
expression of virulence factors, we sought to investigate the mechanism of how 
yapE was being regulated. To this end, we used a transposon mutagenesis 
screen to try to identify gene(s) responsible for yapE regulation. We performed a 
10-fold coverage of the Y. pestis genome and were able to isolate 100 clones 
that had the blue phenotype representing an insertion into a possible regulator of 
yapE either a positive regulator or a negative regulator. What we found is ~85% 
of the transposons inserted themselves into our reporter or sugar transport and 
metabolizing genes. The remaining clones were either not verifiable due to not 
being able to locate the inverted repeats or we were unable to obtain verifiable 
data from sequencing. We did find one insertion a filamentous phage, YpfΦ that 
has been shown to confer some selective properties to Y. pestis during the 
infection process [91].  
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Filamentous phage infections produce the protein, phage shock protein, when 
the bacteria are in stressful conditions [92]. When infection occurs from the flea 
vector to the human host, Y. pestis goes through copious changes due to its 
ability to infect two different host the flea at 26°C and the mammalian host at 
37°C. Once inside the mammalian host, the bacteria are subjected to 
temperature shift, pH change, in addition to the influx of neutrophils and 
macrophages that phagocytize the bacteria placing them under highly stressful 
conditions. Lenz showed that using environmental cues in vitro had no effect on 
yapE transcription levels but in vivo (37°C) they showed that yapE transcript 
increased 15-fold by 72 hours [74]. This indicates that there may be other stress 
inducers or environmental cues in vivo that may influence transcription levels of 
yapE. 
Although we were not able to detect any yapE transcription by way of our 
reporter, this may be due to the length of time the bacteria was placed in high 
stress environment (up to 12 hours). Lenz showed the increase of transcript of 
yapE, in vivo, was between 48 and 72 hours [74]. The time points analyzed here 
may not have been long enough to allow for the regulator to be induced.   
In addition to the genes of the phage, we also cannot rule out the possibility that 
this was another case of false positive due to a lacI transcriptional regulatory 
protein downstream of the phage related membrane proteins (Fig. 2-2) and the 
insertion in the phage operon may have induced expression of this gene and 
production of a cryptic β-galactosidase.  
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Another caveat to the transposon screen is that yapE expression is already low 
in vitro. When designing the reporter, there is a chance there was YapE 
expression but the limit of detection by Western blot was not able to detect the 
protein. Alternately, YapE expression in a potential yapE regulatory mutant may 
have been toxic. To try to avoid this, I used a ∆yapE strain. 
When identifying gene regulators, there is the possibility that regulation may be 
multifactorial. The screens limitation is that it did not taking into consideration the 
impact of temperature, pH, oxygen or other environmental cues may have on 
yapE regulation. In the future, screens for yapE regulators should be performed 
in the presence of factors that mimic the host would be advantageous. This 
would include growing the cultures containing the transposon insertion at both 
26° and 37° and in the presence of 5% CO2. Because yapE is upregulated in the 
host, another possibility is to use to perform the screen in macrophages. After 
infection, macrophages could be lysed and bacterial RNA purified and perform 
qRT-PCR performed on yapE to determine if insertion influences transcriptional 
change in yapE. 
An alternative possibility is that the regulator may be a sRNA. Small RNAs, are 
small (50-250 nucleotide) non-coding RNA molecules produced by bacteria [93]. 
These small molecules have been shown to have regulatory function that 
include, gene expression that affects protein synthesis at the post-transcriptional 
level [94].  We may have missed sRNAs in our transposon mutagenesis screen 
due to their small nature.   
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Although we were unable to identify a regulator of yapE, we believe that this 
should be followed up using alternative methods and to possibly investigate 
sRNAs as possible regulators that would not be identified by this method. 
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Table 2-2 Growth and stress conditions of Yersinia autotransporter 
proteins 
 
Bacteria Type of stress Results 
Y.pestis Temperature (not extreme 
temp) 
 ≥2-fold @37°-yapF, yapJ, yapK, 
yapL and yapM 
 15-fold increase in yapE (in lymph 
nodes) 
 Calcium  Only 2 genes responded to CA 
levels, yapK and yapM. 
 yapM was induced @26° and  
 yapK was repressed in the 
presence of calcium at 37° 
 other yap genes showed no change 
in expression levels 
 Iron yapM was the only gene found to be 
responsive to low-iron conditions where it 
was repressed at both 26° and 37° 
 pH  Under acidic conditions (pH 6.0) no 
yap genes were induced 
 @ pH of 6.0 yapG was repressed 
>2-fold 
 @pH of 8.0 yapG was repressed 
2.5 fold @ 26° 
 yapH was induced 3.5-fold at pH 
8.0 and 26° 
 
Table adapted from Lenz, JD et al., 2011 [74] 

















Figure 2-3. There is no secondary insertion in clone YR076. Plasmid DNA 
from the reporter (pFU99), YR076, and a clone containing an inserted 
transposon in the reporter (YR100) was linearized using BamHI and ran on a 
0.8% agarose gel. The reporter and clone YR076 both migrated to approximately 
6.8 kb showing that there is no other insertion found in YR076. 
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Figure 2-4. Growth curve of YR076 clone. Growth curve showing OD600 
readings over 8 hours of growth when clone YR076 is induced with IPTG and not 
induced compared with the vector strain YPA111 (pFU99::yapE) and the wild-
type strain YPA035 (CO92 pCD-). 2-way ANOVA showed no significance at the 8 
hour time point. 
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Figure 2-6. Western blot analysis of inducible phage plasmid. YPA001 w/ 
YapEYpestis tetO expresion plasmid (YPA024) and the phage-inducible plasmid 
(YPA131) induced and uninduced were grown at 26°. Whole cell lysate was 




Figure 2-7. The native phage, YpfΦ, was not induced by salinity or 
osmolarity. The reporter strain (YPA111) was grown at 26° in the presence of 
5M NaCl2 or 5M sorbitol for 20 minutes and yapE::lac expression was measured 
by Miller Assay. The clone containing the transposon insertion into the phage, 
YR076, was induced with IPTG and used as a positive control. YPA111, grown in 








Figure 2-8. Low Magnesium is not an environmental cue for YapE. 
The reporter strain (YPA111) was grown at 26° in the presence of 10 µM MgCl2 
or 1mM MgCl2 and a Miller Assay was performed to measure yapE promoter 
activity at 5, 8, and 12 h. The clone containing the transposon insertion into the 
phage, YR076, was induced and used as a positive control. The reporter strain, 
YPA111, was just grown in media with no added stressors for the negative 
control. Due to the extreme elevation of Miller units for the YR076 (I), this data 









Pla a 9.5 kd protein located on the pPCP plasmid (also known as pPst) of Yersinia 
pestis, and has been shown to be responsible for the invasive property of plague 
in the mammalian host [95]. Pla, a member of the omptin family of enterobacterial 
surface protein, is a multifunctional protein that can activate the mammalian 
plasma proenzyme plasminogen into plasmin [49]. In addition to being able to 
activate plasminogen into plasmin, Pla also cleaves the complement C3 
component [52], modifies bacterium-produced Yops (Yersinia outer proteins) [96, 
97], has the ability to activate adhesins (YapE) and proteolytically inactivates α2-
antiplasmin [98, 99].  
YapE facilitates contact between bacteria and eukaryotic cells through its adhesive 
properties [76]. Lawrenz and co-workers showed that YapE adhesive properties is 
predicated upon its cleavage by Pla. This was the first indication that Pla may 
cleave other bacterial outer membrane proteins. 
Therefore I sought to determine if other Y. pestis outer membrane proteins are 
cleaved by Pla.  
Material and Methods: 
Membrane Fractionation 
Y. pestis CO92 pCD1(-)  (with and without pla) were grown, overnight, at 26°C in 
Brain Heart Infusion (BHI) broth (Difco).  The overnight culture was then sub-
diluted into BBL BHI, where CaCl2 was added to the media at a final concentration 
of 2.5 mM and allowed to agitate on a floor shaker for approximately 3 hours at 
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26°C and 37°C. The bacteria was grown to an optical density of ~2 OD600/ml and 
approximately 300 ODs were harvested. The harvested bacteria was then 
centrifuged for 10 minutes at 4,000 xg at 4°C. The supernatant was removed and 
the bacteria were washed 3X with 25 mls of 10 mM HEPES, pH 7.5, 1x protease 
inhibitor.  Bacteria was re-suspended into 10 mM HEPES, pH 7.5, 1x protease 
inhibitor and transfer to 50 ml conical for sonication. The bacteria was then 
sonicated in 3 cycles at 30% amplitude for one minute on ice. The sonicated 
fractions were then centrifuged for 2 minutes at 1,000 x g at 4°C.  The supernatant 
was transferred into ultracentrifuge tubes for ultracentrifugation at 100,000 xg for 
30 minutes at 4°C. Supernatant was removed and the pellet was re-suspended in 
0.3% Sarkosyl, 10 mM HEPES, pH 7.5, 1x Protease inhibitor and incubated at 
room temperature for 30 minutes. The outer membranes were pelleted by ultra-
centrifugation at 100,000 x g for 30 min. at 20°C. The inner membrane proteins in 
the supernatant were removed and the pellet was dissolved in molecular grade 
water. 
Chloroform-methanol extraction 
To the outer membrane fraction methanol was added and vortexed thoroughly. 
Chloroform and water were added, vortexed, then centrifuged for 1 min at 14,000 
x g. The top aqueous layer was removed and placed in a separate Eppendorf 
tube where methanol was added and vortexed. The fraction was then centrifuged 
for 5 min at 20,000 x g. The methanol was removed leaving a pellet that contains 
the outer membrane proteins. The pellet was then lyophilized by speed vac. The 
pellet was then sent to ABI for 2-D gel analysis. 
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2-D gel analysis 
2-D DIGE gel analysis was performed on the lyophilized protein sample (~500 
ug) from the outer membrane prep stated previously.  The sample was sent to 
AppliedBiomics where they performed 2-D DIGE analysis on the 4 samples 
consisting of WT CO92 Y. pestis at 26° and 37° and CO92 Δpla at 26° and 37°.  
2-D DIGE analysis consist of cross-gel analysis containing an internal control, 
comprised of an equal mix of all 4 samples, loaded on both of the analytical gels. 
The first analytical gel compared the protein profile of WT CO92 Y. pestis at 26° 
and CO92 Δpla at 26°and the second gel consisting of WT CO92 Y. pestis at 37° 
and CO92 Δpla at 37°. By having an internal standard being loaded on both gels 
allowed for the comparison of spots across the two gels.   
The protein expression profiles acquired by AppliedBiomics consisted of: i) the 
raw data of both gels (WT26°/Δpla26° and WT37°/ Δpla37°),ii) a protein ID 
number, iii) master number, iv) appearance, and v) ratio treatment/control. 
 
Gel image report. The overlay of both gel images were compared where the red 
and green spots represent up- and down- regulated proteins, respectively.  
DeCyder analysis software was employed to analyze the quantitative changes in 
protein between the samples. The software was able to calculate the log value of 
the standardized abundance of the selected spot for each sample.  The samples 
were then grouped into control and treatment and the average was taken of each 
group.  It also allowed for the evaluation of the fold change (increase of 
decrease) of each spot was indicated.  
44 
Results: 
2DIGE and MS/MS determination of outer membrane proteins processed by Pla 
To ascertain outer membrane proteins whose expression changes when Pla is 
absent or present, I employed the methods of 2-DIGE and mass spectrometry. 
WT and ∆pla strains were grown at 26° and 37°, outmembrane proteins isolated 
and labeled with a fluorescent dye. Proteins were separated by 2-DIGE and 
compared (WT/∆pla at 26° and 37°) Differences between the proteins were 
analyzed. Applied Biosystems (ABI) was able to identify 76 distinct protein IDs 
that were assigned by their DeCyder software.  Of the 76 proteins identified, we 
chose 10 to further investigate by way of MS/MS. Our criteria for choosing the 
protein was that there was a ≥ 2-fold increase or decrease when grown at both 
26° and 37° between WT and ∆pla. To this end, we chose the proteins identified 
in Fig.1. Of these spots, serine endoprotease (spot 16), SodC (spot 61), 
Glutamine sythetase (spot 63) and Inosine-5’-monophosphate (spot 72) are not 
outer membrane proteins and removed from further consideration. The remaining 
six peptides were two forms of Pla (spot 37 & 48), HmsF (spot 5), OmpA (spot 
40), OmpX/Ail (spot 51) and Omp85/YaeT (spot 9).  
Western blot analysis for Ail and HmsF: 
To confirm the results from 2DIGE, I chose two proteins, Ail and HmsF. Total 
outer membrane proteins were isolated from WT or a Δpla strain of Y. pestis 
grown at 26°C to 37°C and separated by SDS-PAGE. Proteins were probed with 
α-Ail or α-HmsF antibodies. When probing with α-Ail, there was no change in Ail 
expression from 26°C and 37°C or between WT and ∆pla (Fig. 3-2).  When 
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evaluating the difference in protein expression of HmsF, at 26°C there was no 
difference in protein amounts between the HmsF over expressing strain, the pla 
mutant and WT (Fig. 3-3). Conversely, a substantial reduction of HmsF was 
observed at 37°C in WT Y. pestis versus the ∆pla mutant, indicating that Pla 
degrades HmsF.   
Discussion: 
Using a pla mutant we were not surprised that the first and highest on the list was 
Pla itself. Pla is able to autoprocess itself into three forms, alpha, beta, and 
gamma. These forms of Pla consist of α-Pla (43%), β-Pla (30%) and γ-Pla (16%) 
[99]. α-Pla corresponds to the full-size mature Pla where β and γ-Pla are the 
subsequent processing of α-Pla [100] [97, 101]. The autoprocessing of Pla was 
further shown by Kukkonen and co-workers using mutations in Pla that 
compromised its proteolytic activity, resulting in loss of the beta form of Pla.  
During our screen we found it interesting that HmsF was found to be significantly 
increased when Pla was removed from Y. pestis. HmsF [102] is one of two outer 
membrane proteins that are in the hmsHFRS operon. The hmsF operon is 
located in the pgm locus and is required for hemin storage. This operon has been 
showed to play an important role in its ability to block the proventricular valve in 
the flea allowing for the transmission of the bacteria from the flea to mammalian 
hosts [102]. Although Perry and co-workers showed that the expression of the 
hmsHFRS operon was not predicated by temperature we found that there was a 
difference in protein when Pla was absent at 37° [102]. The reason for the 
possible reduction of HmsF at 37°C is that Pla activity is optimal at 37°C where 
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Pla activity is reduced at 26°C.  Since the genes expressed in hmsHFRS operon 
play a role in biofilm formation, this phenotype would not be advantageous to the 
bacteria when moving into a mammalian host. This leads us to conclude that the 
reason that posttranslational modification to HmsF allows for the inhibition of the 
biofilm that is needed for transmission from the flea but would hinder its mobility 
inside of a mammalian host.  
OmpA has been a highly characterized outer membrane protein that has been 
shown to facilitate adhesion to and/or invasion of eukaryotic cells, in addition to 
conferring serum resistance [103]. OmpA has also been shown to mediate 
adhesion and/or invasion of eukaryotic cells and serum resistance [104].  
The attachment invasion locus (Ail) is an outer membrane protein that is 
expressed in all three pathogenic species of Yersinia and is thermally regulated 
and is expressed fully at 37°C [105, 106]. Although Ail is expressed in all three 
species to aid in the adherence of host cells, its role in the virulence of Y. pestis 
is more pronounced. This is due to Y. pestis no longer having functional YadA 
and invasin due to a frame shift mutation or transposon insertion [107]. One of 
Ail’s primary role is to facilitate the attachment to host cells for the delivery of Yop 
effector proteins from the T3SS. In addition to attachment, Ail is also important in 
the evading of host immune responses allowing for rapid progression of infection 
[108].   
It is also important to note that the regulation of these genes are varied with 
respect to pla expression (Table 3-3).  To this end, we have a better 
understanding of the dual nature of Pla and its interplay among various outer 
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membrane proteins and possible explanations on its attenuation when mutated 
outside of a reduction in dissemination, but also the attenuation it has 
intracellularly. Although we only evaluated the top 10 proteins, other proteins 
identified in the 2-D gel analysis may give us further insight into novel proteins 








Figure 3-1. 2-DIGE outer membrane protein spot identification. Outer 
membranes from WT (green) and ∆pla (red) grown at 37°. The first analytical gel 
compared the protein profile of WT CO92 Y. pestis at 26° and CO92 Δpla at 26°and the 
second gel consisting of WT CO92 Y. pestis at 37° and CO92 Δpla at 37°. The overlay 
of both gel images were compared where the red and green spots represent up- and 
down- regulated proteins, respectively. The white circles indicate proteins where the 
ratios were ≥2-fold difference between temperature and strain. The pink circles 









Figure 3-2. Western blot analysis of  Ail at 26°C and 37°C in the presence or 
absence of pla  .  WT and ∆pla strains were grown to mid-exponential phase at 
26°C and 37°C and collected by centrifugation. Outer membrane proteins were 
extracted, and 1.5 OD600 of each sample was analyzed by Western blot and 














Figure 3-3.    Western blot analysis of HmsF in the presence and absence of 
pla at 37°C. WT and ∆pla strains were grown to mid-exponential phase at 26°C 
and 37°C and collected by centrifugation. Outer membrane proteins were 
extracted, and 1.5 OD600 of each sample was analyzed by Western blot and 
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Table 3-3. Yersinia pestis outer membrane regulators. 
Gene Regulator  Upregulated at 26° Upregulated at 37° 
pla cyclic AMP 
receptor protein 
(Crp) 
             √ 
hmsF fur         √  
ompA micA            √ 
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Many bacterial pathogens have evolved mechanisms to infect and survive 
within host cells. Therefore, in order to study and understand the pathogenesis of 
intracellular pathogens, cell culture-based in vitro assays have been developed. 
For obligate intracellular pathogens, like Chlamydia species, which cannot grow 
outside of a host cell, these assays are relatively straight forward. Bacteria are 
added directly to cells, allowed to adhere and invade for a certain period of time, 
and the remaining extracellular bacteria are removed by washing the cells [109, 
110].  However, for facultative intracellular bacteria that can also replicate in 
tissue culture medium, additional steps are needed to inhibit the growth of 
extracellular bacteria not removed by washing. The most common approach to 
limit extracellular growth is to include an antibiotic to the medium after bacteria 
have had time to invade cells. Importantly, the antibiotic chosen should have a 
limited ability to cross the plasma membrane of the cell. Thus, intracellular 
bacteria are protected from the antibiotic while extracellular bacteria are inhibited 
by the antibiotic (commonly referred to as an antibiotic protection assay) [111, 
112].  Application of the antibiotic protection assay has allowed the study of 
intracellular virulence mechanisms across multiple facultative intracellular 
bacteria [113].  
While the antibiotic protection assay is commonly used to study intracellular 
pathogens, strong evidence indicates that antibiotics originally thought to be 
completely excluded by the host cell can slowly enter and accumulate within 
cells. For example, aminoglycosides such as streptomycin and gentamicin are 
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often employed in the antibiotic protection assay because they are not lipid 
soluble and original studies indicating poor cell permeability [114-116]. However, 
subsequent studies have demonstrated that despite poor membrane 
permeability, aminoglycosides can still accumulate within cells to levels that 
inhibit bacterial growth, especially for organisms that remain in vacuolar 
compartments. Such phenomenon has been reported for antibiotic protection 
assays involving Listeria monocytogenes, Salmonella enterica, Staphylococcus 
aureus, and E. coli [117-120]. The increased sensitivity of organisms within 
phagosomal compartments to aminoglycosides, as opposed to those that escape 
into the cytoplasm, has been attributed to the believed primary route of antibiotic 
uptake – pinocytosis of the extracellular milieu [117]. Pinocytosed vesicles 
containing the antibiotic in turn readily fuse with phagosomes/endosomes, 
delivering the aminoglycoside to the bacterial containing compartment. However, 
it should be noted that aminoglycosides have also been shown to accumulate in 
the cytosol depending on the cell type used and length of incubation time with the 
antibiotic, and thus, addition of aminoglycosides may also artificially influence 
intracellular growth of cytoplasmic pathogens [117, 121]. Therefore, these data 
should be taken into consideration when designing antibiotic protection assays to 
study intracellular growth. 
Yersinia pestis, the causative agent of plague, is a facultative intracellular 
pathogen that is able to invade and replicate in host cells [58, 78, 81, 82, 122-
124]. Of particular interest has been Y. pestis intracellular survival in 
macrophages [81, 125]. However, Y. pestis has also been shown to survive in 
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epithelial cells [107] and more recently, within neutrophils [122, 126-128]. As Y. 
pestis does not express many extracellular virulence factors in the flea vector, 
it is believed that intracellular survival is important during the early stages of 
infection after transmission from the flea, and provides a protective niche for 
the bacterium to initiate expression of the factors needed to exist extracellularly 
[81, 82, 88, 124, 129].  Once Y. pestis invades a cell, it is able to generate a 
replicative niche within a phagosomal compartment (called the Yersinia 
containing vacuole or YCV) by subverting the normal maturation of the 
phagosome [83, 130-132]. The YCV appears to be maintained throughout the 
intracellular infection until the host cell eventually lyses, releasing the bacteria 
into the extracellular environment [131].  
As Y. pestis is able to grow in most cell culture media, in order to study 
intracellular interactions with host cells in vitro, the antibiotic protection assay is 
needed to inhibit extracellular growth. In most cases gentamicin is the primary 
antibiotic employed for Y. pestis intracellular studies because the bacterium is 
sensitive to the antibiotic (MIC ~2 µg/ml) [133]. Surprisingly, in light of the 
potential influence gentamicin has on the intracellular growth of other bacteria, 
a large variety of gentamicin concentrations (ranging from 0.016-256 µg/ml) 
and incubation times (from 15 min to 2 h) have been reported in the Y. pestis 
literature [78, 122, 134-138]. Not surprisingly, variation in Y. pestis intracellular 
survival has also been observed. Importantly, characterization of potential Y. 
pestis pathogenesis factors involved in intracellular infection, or attempts to 
repeat published data, could be influenced simply by the concentration of 
58 
gentamicin used in the antibiotic protection assay. Therefore, we felt it was 
imperative to understand the potential influence of gentamicin concentrations 
on Y. pestis intracellular growth in order to eliminate any potential for 
unintended influence of the gentamicin protection assay on the interpretation of 
intracellular studies with Y. pestis. 
 
MATERIAL AND METHODS 
Cell culture and bacterial strains 
Primary peritoneal macrophages were harvested from 8-12 week old C57/Bl6 
mice (University of Louisville IACUC Protocols 16651 and 16723) injected with 3 
mls of sterile Brewer’s thioglycolate medium. Four days after injection, mice were 
humanely euthanized and peritoneal macrophages were recovered in 20 mls of 
Hank’s Buffered Salt Solution (HBSS). Cells were isolated by centrifugation and 
resuspended in 10 mls of DMEM (DMEM, 100 mM glucose, sodium pyruvate; 
Hyclone) + 10% FBS (Biowest) as previously described [139]. Cells were 
quantified, transferred to microtiter plates or dishes, and allowed to adhere for 3 
h. Non-adherent cells were then removed from adherent macrophages by 
washing with HBSS three times. RAW264.7 macrophages were originally 
obtained from ATCC and cultured in DMEM + 10% FBS. RAW264.7 cells were 
propagated for only up to 15 passages for these studies. Y. pestis strains used in 
these studies are listed in Table 1. Bacteria were propagated in Difco Brain Heart 
Infusion (BHI) (BD, Co.). We have previously shown that the bioluminescence 
generated by the LuxPtolC bioreporter directly correlates with bacterial numbers 
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and can be used to kinetically monitor Y. pestis intracellular survival in 
gentamicin protection assays [130, 140]. 
Live Cell Microscopy 
5 x 105 peritoneal macrophages in FluoroBrite DMEM (ThermoFisher), 4 mM 
glutamine + 10% FBS were added to a 35 mm glass bottom FluoroDish (World 
Precision Instruments). Macrophages were allowed to adhere to the dish for 3 h 
prior to infection. Y. pestis was grown overnight in BHI broth at 26oC and then 
diluted 1:25 in fresh BHI broth and grown for an additional three hours until the 
culture reached an absorbance at 600 nm of ~1.0. The bacteria were diluted into 
FluoroBrite DMEM, 4 mM glutamine + 10% FBS and added to macrophages at a 
multiplicity of infection (MOI) of 3 bacteria per macrophage. To facilitate cell-
bacteria interactions, FluoroDishes were centrifuged at 200 x g for 5 minutes and 
returned to the CO2 incubator. Fifteen min later, the medium was removed, the 
cells were washed three times with sterile 1X PBS to remove extracellular 
bacteria, and fresh FluoroBrite DMEM, 4 mM glutamine + 10% FBS was added. 
Live imaging was performed using a Nikon A1 confocal microscope (Nikon 
Instruments, Inc.) with a live cell chamber equilibrated to 5% CO2 and 37°C prior 
to imaging. Either a 488 nm or 561 nm laser with filter sets 525±50 nm or 595±50 
nm were used to visualize EGFP or mCherry, respectively. Images were taken 
using a 40x Plan Fluro Oil objective every 20 min beginning 1 h post-infection 
and continuing for 24 h. The Nikon Perfect Focus System and field tiling were 
used to collect six fields (287 x 287 µM per field) at each time point. Bacterial 
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numbers were estimated by calculating the area of the fluorescent signal for each 
field using FIJI [141].   
Monitoring bacteria using a bioluminescence  
1.5 x 105 macrophages were aliquoted into the wells of a white 96 well microtiter 
plate (Greiner Bio One) and allowed to adhere for 3 or 15 h (peritoneal or 
RAW264.7 cells, respectively).  Y. pestis was grown overnight in BHI broth at 
26oC and then diluted 1:25 in fresh BHI broth and grown for an additional three 
hours until the culture reached an absorbance at 600 nm of ~1.0. The bacteria 
were diluted into 37oC DMEM +10% FBS and added to macrophages at a MOI of 
10 bacteria per macrophage. To facilitate cell-bacteria interactions, microtiter 
plates were centrifuged at 200 x g for 5 minutes and returned to the CO2 
incubator for an additional 15 minutes, at which point gentamicin was added 
directly to the wells without washing to achieve the final desired concentrations. 
Concentrations of gentamicin used were not cytotoxic to macrophages. Bacterial 
numbers as a function of bioluminescence produced by the LuxPtolC bioreporter 
[130, 140] was monitored kinetically to limit manipulation of the macrophages 
using a Synergy HT plate reader (0.5 sec read, sensitivity of 135) (BioTek) or 
IVIS Spectrum camera system (15 min read, 500 nm emission filter) (Caliper).  
Determination of gentamicin minimal inhibitory concentration  
Y. pestis was grown overnight in BHI broth at 26oC and then diluted 1:25 in fresh 
BHI broth and grown for an additional 3 h until the culture reached an 
absorbance at 600 nm of ~1.0. The bacteria were diluted into 37oC DMEM + 10% 
FBS and aliquoted at 1.5 x 106 CFU per well in a 96 well plate. Gentamicin was 
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diluted in 37oC DMEM + 10% FBS and added to the bacteria to achieve the final 
desired concentration (0 – 128 µg/ml). One h after treatment, bacterial numbers 
were determined by conventional enumeration using serial dilution and plating on 
BHI agar [140].  
Enumerating intracellular bacteria by conventional enumeration 
For short incubations with the antibiotic, bacterial numbers were directly 
enumerated by serial dilution to allow for separate calculations of extracellular 
and intracellular bacterial numbers after gentamicin treatment. Macrophages 
were infected with Y. pestis as described above and treated with gentamicin for 1 
h. After treatment with gentamicin, the culture medium was collected into a 
separate tube, the cells were washed three times with sterile 1X PBS, which was 
also collected and combined with the collected medium, the combined medium + 
1x PBS washes was serial diluted and plated on BHI agar plates to enumerate 
the extracellular bacteria. For the intracellular bacteria, washed macrophages 
were lysed with 0.1% Triton X100 and serial dilutions were plated on BHI agar 
plates for enumeration [140]. 
Statistical Analysis  
All studies were repeated three times to ensure reproducibility. When needed, 
mean values from individual treatment groups were compared to the 0 µg/ml 
gentamicin group using the ANOVA with the Dunnett’s post test or across all 
samples with the Tukey post test. A p-value less than 0.5 was consider to be 




Macrophage - Y. pestis interactions in the absence of gentamicin. To 
establish the fate of Y. pestis during infection of macrophages in the absence of 
gentamicin treatment, primary peritoneal macrophages were infected with a Y. 
pestis strain expressing the mCherry fluorescent protein (YPA165). 20 min post-
infection, the macrophages were washed to remove extracellular bacteria and 
imaged every 20 min by laser confocal microscopy for 24 h (data not shown). 
Changes in bacterial number, as a function of the total area of mCherry signal, 
were calculated at each time point (Fig. 4-1). Over the first ~12 h, most bacteria 
appeared to be intracellular and we observed a steady increase in the area of 
mCherry over time, indicating intracellular survival and growth (Fig. 4-1A). 
However, a small number of infected macrophages began to lyse ~12 h post-
infection and release Y. pestis into the culture medium, though cell death was not 
synchronous and most infected cells were still intact through the first 18 h (Fig 4-
1C). We continued to observe increases in the area of mCherry through 24 h of 
observation (Fig. 4-1B), and while bacteria appeared to continue to grow 
intracellularly, extracellular bacteria released from dead macrophages were also 
replicating in the medium and represented a large portion of the mCherry signal 
at later time points (Fig. 4-1B and C). By 24 h post-infection, almost all of the 
infected macrophages had lysed and the majority of the mCherry signal was from 
extracellular bacteria (Fig. 4-1C). 
To determine if the Y. pestis Ysc type 3 secretion system (T3SS) influenced the 
intracellular fate of the bacterium, macrophages were infected with a Y. pestis 
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strain lacking the pCD1 virulence plasmid encoding the Ysc T3SS and 
expressing EGFP (YPA081) and imaged by laser confocal microscopy as 
described above. As observed for the T3SS positive strain, total area of EGFP 
increased over the entire course of the experiment (Fig. 4-1A and B). However, 
unlike the Y. pestis pCD1(+) strain, we did not observe macrophage lysis, 
bacterial release, or extracellular proliferation over the 24 h time frame of the 
experiment, indicating that the increased area of EGFP was a function of only 
intracellular growth. Together these data: 1) confirm data from previous in vitro 
assays that Y. pestis survives intracellularly in primary macrophages [123, 132]; 
2) confirm that Y. pestis lacking the T3SS can survive in macrophages [78, 123, 
132]; 3) demonstrate that macrophages infected with Y. pestis with a functional 
T3SS lyse more rapidly than macrophages infected with Y. pestis lacking the 
T3SS; 4) macrophage cell death releases intracellular bacteria into the 
environment; and 5) bacteria released from macrophages are viable and can 
replicate in the cell culture medium. While intracellular vs. extracellular bacteria 
can be differentiated during live imaging, in vitro assays that do not use 
microscopy are not able to differentiate between the two, thus requiring the use 
of an antibiotic protection assay. However, as a wide variety of concentrations of 
gentamicin have been reported in the Yersinia literature [78, 122, 134-138], we 
next wanted to determine if extended incubation with gentamicin could influence 
intracellular proliferation of Y. pestis. 
Extended incubation with gentamicin impacts intracellular survival of Y. 
pestis. The simplest antibiotic protection assay would be to add gentamicin to 
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the infected cells and maintain that concentration in the medium throughout the 
entire course of the study. However, extended incubations have been shown to 
influence the intracellular proliferation of other bacteria [111, 117, 118]. To 
determine if extended incubations with gentamicin impacted survival of 
intracellular Y. pestis, peritoneal macrophages were infected with a Y. pestis 
strain containing the LuxPtolC bioreporter (YPA050), which we have previously 
shown can be used to accurately monitor intracellular Y. pestis as a function of 
bioluminescence [130, 140]. Twenty min post-infection, serial dilutions of 
gentamicin were added to each well to achieve final concentrations of 128 to 1 
µg/ml and beginning 2 h after infection, and bacterial numbers, as a function of 
bioluminescence, were determined every 3 h for 20 h using a plate reader. We 
observed that at the lowest concentrations tested, 1 and 2 µg/ml, that bacterial 
bioluminescence increased over time, although at 2 µg/ml, bioluminescence was 
approximately 2-3 fold lower than at 1 µg/ml (Figure 4-2A and 4-2B).  At 
concentrations greater than 2 µg/ml, bioluminescence no longer increased, 
indicating that bacteria were no longer able to proliferate. At 4 µg/ml, we 
observed an initial decrease in bioluminescence between 2 and 5 h, at which 
time bioluminescence remained constant over the remainder of the assay. 
Gentamicin concentrations greater than 4 µg/ml resulted in a steady decrease in 
bacterial bioluminescence over the entire course of the assay (Fig. 4-2D-H). 
Compared to our live imaging experiments without gentamicin, these data 
demonstrate that extended incubation with even low concentrations of 
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gentamicin can have a dramatic influence on Y. pestis intracellular survival, and 
can lead to intracellular killing of the bacterium.  
 
Sensitivity to gentamicin is cell type dependent.  As pinocytosis is suggested 
to be the main mechanisms for gentamicin uptake by macrophages, sensitivity of 
intracellular bacteria to gentamicin could vary depending on cell type used. 
RAW264.7 cells are an immortal cell line originally derived from mouse 
macrophages and are commonly used as a macrophage model [142]. To 
determine if the sensitivity of intracellular Y. pestis to gentamicin could vary 
depending on cell type, RAW264.7 cells were infected with Y. pestis YPA050. 20 
min later, serial dilutions of gentamicin were added to each well to achieve final 
concentrations of 128 to 1 µg/ml and cells were incubated for 20 h. Bacterial 
numbers were monitored as a function of bioluminescence, normalized to T=2 h, 
and compared to similarly treated primary peritoneal macrophages (Fig. 4-3). 
Similar to peritoneal cells, bacterial bioluminescence increased in RAW264.7 
macrophages when treated with 1 µg/ml, indicating intracellular proliferation. 
However, unlike bacteria in peritoneal macrophages, Y. pestis bioluminescence 
continued to increase in RAW264.7 cells until gentamicin concentrations reached 
16 µg/ml. After 16 µg/ml, bioluminescence began to decrease overtime, 
indicating bacterial killing, and approached levels similar to that seen for 
peritoneal macrophages at 128 µg/ml. These data highlight that gentamicin 
inhibition of intracellular Y. pestis can vary between cell types.  
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Short incubation with high concentrations of gentamicin inhibits 
intracellular growth. Since extended incubations with gentamicin dramatically 
inhibited the proliferation of intracellular Y. pestis, we next sought to identify the 
minimal concentration of gentamicin needed to inhibit Y. pestis growth in tissue 
culture medium in a 1 h period. Towards this end, Y. pestis YPA050 was diluted 
in DMEM, 10% FBS with increasing concentrations of gentamicin. One h after 
addition of gentamicin, bacteria were serially diluted and plated on BHI agar to 
determine remaining viable bacteria (Fig. 4-4A). All doses of gentamicin tested 
resulted in a significant decrease in the number of recovered bacteria compared 
to untreated (p≤ 0.0001) and the degree of inhibition was dependent on the 
concentration of the antibiotic. While bacteria were reduced ~1,000-fold within 
one h with 4 µg/ml gentamicin, no detectable viable bacteria were recovered after 
incubation with ≥8 µg/ml. Similar inhibition was observed for the Medivalis biovar 
KIM D19 (Fig. 4-7).   
Next we sought to determine whether the presence of macrophages impacted 
the minimal concentration of gentamicin required to inhibit Y. pestis growth in cell 
culture medium. Peritoneal macrophages were infected with Y. pestis YPA050 
for 20 min and serial dilutions of gentamicin were added to each well to achieve 
final concentrations of 128 to 1 µg/ml. One h after addition, the gentamicin 
containing medium was removed and combined with washes and viable 
extracellular bacteria were determined by serial dilution and conventional 
enumeration (Fig. 4-4B). Extracellular bacterial numbers were significantly lower 
in all the samples that received greater than 1 µg/ml of gentamicin as compared 
67 
to absence of gentamicin (p≤ 0.0001). However, no significant differences were 
observed in bacterial numbers between concentrations of 4 to 32 µg/ml. 
Furthermore, while we observed no significant difference in bacterial numbers 
between the 64 and 128 µg/ml concentrations, we observed ~2.5-fold lower 
numbers of extracellular bacteria at 64 and 128 µg/ml samples (average 180 
CFU) compared to the 4 to 32 µg/ml samples (average 458 CFU) that was 
statistically significant (p≤ 0.05). 
Finally, we enumerated the number of intracellular bacteria in macrophages 
after 1 h treatment with gentamicin at both 1 and 24 h post-treatment to 
determine if gentamicin concentration during short incubations could impact 
intracellular survival of Y. pestis (Fig. 4-5). At 1 h post-treatment, statistically 
significant differences in the number of intracellular bacteria recovered were not 
observed until gentamicin concentrations were greater than 8 µg/ml (Fig. 4-5A). 
In concentrations greater than 8 µg/ml, a dose dependent decrease in viable 
intracellular was observed. However, even at the highest doses, intracellular 
numbers only varied by ~1.3-fold as compared to macrophages receiving lower 
doses of antibiotic. To determine if long term intracellular survival of Y. pestis 
was affected by short exposures to gentamicin, a separate group of infected cells 
were washed 1 h after gentamicin treatment to remove residual gentamicin and 
fresh medium without gentamicin was added. 23 h later, the medium was 
removed, the cells were washed, lysed, and intracellular bacterial numbers were 
enumerated (Fig. 4-5B). We observed bacterial proliferation in all samples 
containing less than 64 µg/ml gentamicin, and there were no significant 
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differences in intracellular numbers in samples containing 0 to 32 µg/ml 
gentamicin. However, bacteria did not proliferate in macrophages treated with 64 
µg/ml of the antibiotic, and at the highest dose of 128 µg/ml, intracellular bacterial 
numbers decreased over time. Together these data indicate that at least 4 µg/ml 
of gentamicin is required to achieve optimal killing of extracellular Y. pestis in 1 h 
during macrophage infection assays. However, as gentamicin concentrations 
increase, even short incubations with the antibiotic can impact proliferation of 
intracellular Y. pestis, especially at higher doses of the antibiotic.  
 
Optimized gentamicin protection assay for Y. pestis 
Together these data suggest that an optimized gentamicin assay for Y. pestis 
should include two doses of gentamicin. The first should be an initial dose to 
efficiently kill the majority of the extracellular bacteria in a short incubation period 
(e.g., one hour) without inhibiting intracellular survival. The data from short term 
incubations with gentamicin (Fig. 4-5) suggest that this concentration should not 
exceed 8 µg/ml. After the one hour incubation, the medium should be removed 
as continued incubation in 8 µg/ml results in inhibition of intracellular bacteria 
(Fig. 4-2). The medium should then be replaced with a lower dose that inhibits 
extracellular bacterial growth but not intracellular survival of the bacteria during 
extended incubations. The data from extended incubations with gentamicin (Fig. 
4-2) suggest that this maintenance dose should not exceed 2 µg/ml. To test 
these empirically derived gentamicin concentrations, peritoneal or RAW264.7 
macrophages were infected with YP043, a fully virulent strain of Y. pestis CO-92 
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expressing the LuxPtolC bioluminescent bioreporter [140]. Twenty min later, 
gentamicin was added at a final concentration of 8 µg/ml. Cells were incubated 
for 1 h, washed with 1X PBS, and the medium was replaced with medium 
containing 2 µg/ml gentamicin. Intracellular bacterial survival was monitored by 
bacterial bioluminescence every 2 h for 20 h using an IVIS optical imager (Fig. 4-
6). In peritoneal macrophages, bioluminescence slightly decreased over the first 
~8 h of infection, indicating an initial inhibition of bacterial survival by the 
macrophages, but then at ~12 h, bacterial bioluminescence began to increase, 
reaching a steady state level at 16 h that was maintained for the remainder of the 
infection (Fig. 4-6A). Based on our live imaging experiments, this steady state 
level at later time points likely represents a balance between intracellular 
replication and gentamicin killing of extracellular bacteria from lysed 
macrophages (Fig. 4-1). In RAW264.7 macrophages we did not observe an initial 
decrease in bacterial bioluminescence, supporting that this cell type is more 
permissive to intracellular bacterial infection (Fig. 4-6B). Instead, we observed a 
~2-fold increase in bioluminescence over the first 4 h, which plateaued at this 
level for the first 10 h of the infection. Then, similar to the peritoneal 
macrophages, at ~12 h post-infection, bacterial bioluminescence began to 
increase, indicating further intracellular bacterial proliferation. 
 
Discussion 
The antibiotic protection assay has been a key technique for the study of 
bacterial intracellular pathogenesis. The assay was originally developed on the 
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premise that certain classes of antibiotics are excluded from eukaryotic cells, 
resulting in antibiotic-mediated killing of extracellular bacteria but not intracellular 
bacteria. While researchers have more recently recognized that antibiotics 
originally thought to be excluded can inhibit the growth of several bacterial 
pathogens, only a few systematic studies have been performed to characterize 
the impact of antibiotic treatment on specific pathogens [116, 117]. We took 
particular notice to this in the Yersinia field, where large variations in antibiotic 
concentrations and exposure times have been reported in the literature [78, 122, 
134-138, 143]. We were concerned that such variations in the antibiotic 
protection assay between laboratories had the potential to decrease 
reproducibility of experiments and potentially produce artificial phenotypes due to 
unanticipated influence by the antibiotic. As such, our goals here were to 
specifically demonstrate that variations in the gentamicin protection assay could 
alter Y. pestis intracellular growth and suggest that researchers carefully 
consider antibiotic concentrations and exposure times when designing future 
intracellular experiments with Y. pestis (or any bacteria).  
Through the use of live-cell microscopy we were able to observe Y. pestis 
interactions with macrophages in the absence of gentamicin. These observations 
suggest that washing of infected cells removes the majority of bacteria not 
phagocytosed by the macrophages, resulting in the absence of extracellular 
growth during the first several hours of the experiment. However, infected 
macrophages eventually lyse and release viable Y. pestis into the medium. 
These bacteria then replicate extracellularly. Importantly, our experience with live 
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cell microscopy suggests that macrophage lysis is not synchronized and the 
timing of when macrophages lyse and initiation of extracellular growth can vary 
from experiment to experiment. Therefore, more conventional assays to study 
intracellular proliferation without microscopy will require addition of an antibiotic 
in the medium to ensure that extracellular growth is not mistaken for intracellular 
growth. However, the data reported here also suggest that researchers should 
carefully optimize the gentamicin protection assay to minimize potential artificial 
influence on the system. Using an empirical approach, we defined the maximum 
concentrations of gentamicin that should be used in a two-step gentamicin 
protection assay as 8 µg/ml and 2 µg/ml (Fig. 4-6). These concentrations 
represent the maximum concentrations of gentamicin that inhibit Y. pestis growth 
without demonstrating a significant impact on intracellular numbers (as compared 
to live microscopy in the absence of antibiotic). However, important 
considerations in optimizing intracellular assays are not only antibiotic 
concentration and exposure time, but also how Y. pestis is handled prior to 
interactions with host cells and the cell type being used. For example, while our 
data indicates that one hour incubation with 8 µg/ml of gentamicin is the 
minimum bactericidal concentration for Y. pestis, this was determined for early 
logarithmically growing bacteria. We have observed that for stationary phase 
cultures, 16 µg/ml of gentamicin is required to eliminate all extracellular bacteria 
in one hour [130, 140].  Furthermore, our data comparing peritoneal and 
RAW264.7 macrophages support that researchers should not assume that 
empirically determined gentamicin concentrations that do not influence 
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intracellular growth in one cell type will not alter growth in another. Wendte et al. 
also recognized differences in intracellular Y. pestis sensitivity to gentamicin 
between THP-1 and RAW264.7 macrophages [144]. Therefore, different 
macrophages may require concentrations different from those used here. In 
summary, we hope these studies help researchers reconsider the potential 
impact of gentamicin on Y. pestis intracellular growth when designing future 
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Figure 4-1. Live imaging of Y. pestis in the absence of gentamicin. (A and B) 
Primary peritoneal macrophages were infected with Y. pestis YPA165 expressing 
mCherry (red symbols; pCD(+)) or Y. pestis YPA081expressing EGFP (blue 
symbols; pCD(-)) at a MOI=3. One h after infection, cells were washed to remove 
extracellular bacteria and macrophages were imaged by live confocal 
microscopy. Bacterial numbers as a function of total fluorescent (RLU) area per 
field were determined every 1 h for 24 h. Each point represents the mean ±S.D. 
calculated from four imaged fields at each time point (an average of 16 infected 
cells per field). (C) Representative images of Y. pestis YPA165 infected 
macrophages at indicated time points during the infection. Individual 
macrophages tracked through the entire course of the experiment are outlined in 
different colors. Lysed macrophages at 24 h are highlighted by dotted lines. 
Presence of extracellular bacteria at 18.2 h are highlighted by arrows.  
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Figure 4-2. Extended incubations with gentamicin inhibit Y. pestis 
intracellular survival. Primary peritoneal macrophages were infected with Y. 
pestis YPA050 at an MOI of 10 (n=6). 20 min post-infection, macrophages were 
washed and the medium was replaced with medium containing gentamicin at 
indicated concentrations. Bacterial numbers as a function of bioluminescence 
were determined every 3 h for 20 h using a plate reader and displayed as the 
mean ±S.D. (in some cases the S.D. is smaller than the symbol size). Data is 
shown from one representative experiment of three independent experiments.  
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Figure 4-3. Cell type can influence intracellular sensitivity of Y. pestis to 
gentamicin.  Primary peritoneal macrophages (circles, dotted lines) or 
RAW264.7 macrophages (squares, solid lines) were infected with Y. pestis 
YPA050 at an MOI of 10 (n=6). 20 min post-infection, macrophages were 
washed and the medium was replaced with medium containing gentamicin at 
indicated concentrations. Bacterial numbers as a function of bioluminescence 
were determined every 3-6 h for 20 h using a plate reader. Bioluminescent data 
from each time point was normalized to fold change compared to the 2 h time 
point by dividing each time point by the 2 h time point and is displayed as mean 






Figure 4-4. Minimum inhibitory concentration of gentamicin for Y. pestis. 
Logarithmically growing Y. pestis YPA050 was diluted to 1.5 x106 CFU per well in 
a 96 well plate containing gentamicin at the indicated concentrations. (A) One h 
after inoculation into gentamicin, bacteria were removed, serially diluted in 1x 
PBS, and enumerated on agar to determine bacterial viability after exposure to 
gentamicin (n=3). (B) Primary peritoneal macrophages were infected with Y. 
pestis YPA050 at an MOI of 10 (n=3). 20 min post-infection, gentamicin was 
added at indicated concentrations. One h later, the medium and washes were 
collected, combined, and serially diluted to enumerate viable bacteria by plating 
dilutions on BHI agar. Each point represents one sample and the bars represent 
the mean CFU. The dotted lines indicate the limit of detection. Data is shown 
from one representative experiment of three independent experiments. (A and B) 
ANOVA with Dunnett’s post hoc analysis was used when comparing samples to 
0 µg/ml gentamicin. (B) ANOVA with Tukey’s post hoc analysis was used when 
comparing between the 4 – 32 µg/ml samples. **= p≤0.01; ****= p≤0.0001; ns= 





Figure 4-5. Short incubations with gentamicin impact Y. pestis intracellular 
survival in a dose dependent manner. Primary peritoneal macrophages were 
infected with Y. pestis YPA050 at an MOI of 10 (n=3). 20 min post-infection, the 
medium was replaced with medium containing gentamicin at indicated 
concentrations. One h later, gentamicin was removed, and (A) cells were washed 
three times, lysed with 0.1% Triton, and intracellular bacterial were enumerated 
by serial dilution and plating on BHI agar plates, or (B) fresh medium without 
gentamicin was added and cells incubated for an additional 23 h. At 23 h post-
gentamicin treatment, the medium was removed, cells were washed three times, 
lysed with 0.1% Triton, and intracellular bacterial were enumerated by serial 
dilution and plating on BHI agar plates. Each point represents one sample and 
the bars represent the mean CFU. Data is shown from one representative 
experiment of three independent experiments. ANOVA with Dunnett’s post hoc 
analysis compared to 0 µg/ml gentamicin: *= p≤0.05; **= p≤0.01; ***= p≤0.001; 




Figure 4-6. Optimized gentamicin protection assay. Primary peritoneal 
macrophages were infected with Y. pestis YP043 at an MOI of 10 (n=6). 20 min 
post-infection, macrophages were washed and the medium was replaced with 
medium containing 8 µg/ml gentamicin. One h later, culture medium was 
removed, cell were washed with 1X PBS, and fresh medium containing 2 µg/ml 
gentamicin was added. Bacterial numbers as a function of bioluminescence were 
determined every 2 h for 20 h using an IVIS Spectrum optical imager.  
Bioluminescent data from each time point was normalized to fold change 
compared to the 2 h time point by dividing each time point by the 2 h time point 
and is displayed as mean fold change ±S.D. (in some cases the S.D. is smaller 
than the symbol size). Data is shown from one representative experiment of two 




Figure 4-7. Minimum inhibitory concentration of gentamicin for KIM D19 Y. 
pestis. Logarithmically growing KIM D19 Y. pestis pCD1(-) LuxPtolC was diluted to 
1.5 x106 CFU per well in a 96 well plate containing gentamicin at the indicated 
concentrations. (A) One h after inoculation into gentamicin, bacteria were 
removed, serially diluted in 1x PBS, and enumerated on agar to determine 
bacterial viability after exposure to gentamicin (n=3). Each point represents one 
sample and the bars represent the mean CFU. The dotted lines indicate the limit 
of detection. Data is shown from one representative experiment of three 
independent experiments. ANOVA with Dunnett’s post hoc analysis compared to 













Recent studies have shown that the uptake of Y. pestis by host cells such as 
macrophages, and to a lesser degree, neutrophils, is important for survival and 
replication [122] [132]. During initial infection, outer membrane proteins are 
expressed that aid in the uptake of the bacteria into the phagocytes. Many of 
these outer membrane proteins are adhesins that help mediate adherence to 
eukaryotic cells.  
One adhesin, Ail, has been shown to target neutrophils in vivo, although there 
does not appear to be a specific cell type that it directly mediates binding [145]. 
Although the characteristics of Ail in relation to the T3SS have been extensively 
studied, to date, there is little to no information on the role Ail may play in 
intracellular survival.  The adhesin, OmpA, has been shown to contribute to 
intracellular survival [104]. Bartra and co-workers infected RAW264.7 
macrophages using KIM5-3001 WT strain or an ∆ompA strain, and showed that 
by 24 hours there was a statistical difference in bacterial survival (P<0.05) [104]. 
Two adhesins that have played an integral role in the virulence of Y. pestis are 
YapE and Pla. YapE and Pla have both demonstrated that they mediate 
adherence to macrophages [77]. Moreover, strains deficient in either of these 
adhesins are attenuated in dissemination and colonization of lymph nodes and 
organs [53, 76]. It has been observed that at the site of subcutaneous infection, 
macrophages migrate away from the site and travel to a draining lymph node. 
The absence of either adhesin may cause a reduction of bacteria taken up by the 
macrophages. This reduction of bacteria may have downstream effects that can 
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influence the bacterial colonization. Another possibility for the reduction in 
dissemination and colonization is that these adhesins play a role in intracellular 
survival. 
To confirm the role these known adhesins may play in intracellular survival, 
strains lacking these genes (∆ail, ∆ompA, ∆yapE, and ∆pla) were used to infect 
macrophages and their survival was monitored by bioluminescence.    
Results:  
Absence of outer membrane adhesins can influence intracellular survival 
To investigate intracellular survival of the above mentioned adhesins, I used a 
bioluminescent reporter strain containing individual mutations in ail, ompA, yapE 
or pla and compared survival against WT Y. pestis (Table 5-1) in RAW264.7 
macrophages. Macrophages were infected with an MOI of 10 monitored over 22 
h. YPA147 (∆ail) showed no change in intracellular survival compared to WT 
over the course of the experiment (T=22h) (Fig 5-1).  Conversely, there was a 
significant reduction of viable bacteria seen in the YPA148 (∆ompA) strain 
compared to WT by the 11h time point and continued for the duration of the 
experiment (T=22 h) (P<0.0001) (Fig 5-2).  YPA145 (∆pla) showed a reduction in 
bacterial numbers starting at 12 h post-infection (P<0.01) and showed higher 
statistical significance at 24 h (P<0.0001) (Fig. 5-3). YPA087 (∆yapE) showed 





Adhesins are important to the spread of disease due to their ability to adhere to 
eukaryotic cells, avoid complement and other subversions of the immune system. 
These systems are in place to help with the fitness of the bacteria and allow for 
increased virulence.  I have shown that Ail does not impact intracellular survival, 
while an ompA mutant does have a survival defect intracellularly [104]. Although I 
did observe a survival defect with the ompA mutant, it is not due to reduced 
adherence or invasion. Bartra and co-workers examined the initial uptake, by 
cultured macrophages, of an ompA mutant and an isogenic ompA+ strain and 
found the uptake comparable [104]. It was only at the later time point they saw a 
reduction in bacterial numbers. This is because OmpA does not have the same 
function of promoting adherence and invasion in Y. pestis like other bacterial 
pathogens; to this end, their data identified ompA as a pro-survival gene that 
promotes intracellular survival in Y. pestis [104]. The two other adhesins that 
have played an integral role in the virulence are YapE and Pla. The intracellular 
attenuation of ∆yapE, although statistically significant, may not be biologically 
significant. There was a more significant attenuation at the 10 h time point than 
seen at 24 h. This may be in part because other adhesins are compensating for 
loss of YapE.  
For Pla, vanLier and co-workers showed that the single pla mutant was not able 
to survive in RAW264.7 macrophages [143]. I too was able to show an 
attenuated phenotype for a pla mutant intracellularly but not complete clearance. 
To this end, I tried to recapitulate their findings only to show that the clearance 
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they reported may be a byproduct of antibiotic killing by way of the gentamicin 
protection assay. While other studies have shown that there is an attenuation in 
intracellular survival, they showed complete clearance by 12 hours where we 
saw less than a log difference when using 8 µg/ml of gentamicin (Fig. 5-3A). To 
confirm that the concentration of gentamicin was impacting intracellular growth, I 
used 128 µg/ml to kill for 1 hour and saw virtually the same reduction in bacterial 
numbers (Fig. 5-3B). One possible reason for the difference in bacterial 
clearance demonstrated by the van Lier group is that the strain of bacteria they 
used contained the pgm locus where our study did not use a strain containing the 
pgm locus. This is confounding because the rip (required for intracellular 
proliferation) operon is located within the pgm locus that allows for survival and 
replication intracellularly. It would be assumed that if the pgm locus is present the 
bacteria would have an advantage to survive intracellularly where the removal 
should result in the reduction of bacterial numbers. One reason I did not see the 
reduction in bacterial numbers with the ∆pgm strain is that the rip operon is 
important for Y. pestis replication in activated macrophages [146, 147]. When 
performing the gentamicin protection assay, the macrophages were not 
stimulated prior to infection. This is why the absence of the pgm locus did not 
appear to effect intracellular survival in this case.  
Adherence and invasion assays were performed with the yapE and pla mutants 
and for both there was no difference in adherence compared to WT (Fig 5-5 and 
Fig. 5-6 respectively). Although there was a statistical significance see in 
invasion with the pla mutant because the percentage is so minute, I do not 
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believe that this finding is biologically significant. This shows that the adherence 
and uptake by the macrophages is not impacted by the mutations of yapE and 
pla. Further studies are needed to understand the mechanisms that these 
adhesins use that may mediate intracellular survival of Y. pestis. The survival 
defect observed with a pla mutant may also be predicated on other adhesins that 




 Table 5-1. Yersinia pestis strains used in this study. 
Strain Mutation Relevant 
Characteristics 
Bioreporter Source 
YPA143  CO92pgm(-) 
pCD1(+) 
LuxPtolC This study 
YPA145 ∆pla CO92 pgm(-) 
pCD1(+) 
LuxPtolC This study 
YPA147 ∆ail CO92 pgm(-) 
pCD1(+) 
LuxPtolC This study 
YPA148 ∆ompA CO92 pgm(-) 
pCD1(+) 
LuxPtolC This study 
YPA087 ∆yapE CO92 pgm(+) 
pCD1(-) 
LuxPtolC This study 







Figure 5-1 ∆ail does not exhibit an intracellular survival defect. . RAW264.7 
macrophages were infected with Y. pestis YPA147 (n=12) or YPA143 (n=12) at 
an MOI of 10. Bacterial numbers were determined at 5, 11, 17 and, 22h using a 
plate reader measuring bioluminescence. Each time point was normalized to fold 
change compared to the 2 h time point by dividing each time point by the 2 h time 
point and is displayed as mean fold change ±S.D.  (ns = no significance) Data 




Figure 5-2 ∆ompA is attenuated intracellularly. RAW264.7 macrophages were 
infected with Y. pestis YPA148 (n=12) or YPA143 (n=12) at an MOI of 10. 
Bacterial numbers were determined at 5, 11, 17 and, 22h using a plate reader 
measuring bioluminescence. Each time point was normalized to fold change 
compared to the 2 h time point by dividing each time point by the 2 h time point 





















































Figure 5-3 ∆pla is attenuated intracellularly. (A and B) RAW264.7 
macrophages were infected with Y. pestis YPA148 (n=12) or YPA143 (n=12) at 
an MOI of 10. Gentamicin protection assay was used to determine intracellular 
bacteria viability using killing concentrations of 8 µg/ml (A) and 128 µg/m (B). 
Bacterial numbers for each experiment were determined at 2, 4, 8, 12 and 24h 
using a plate reader measuring bioluminescence. Each time point is reflective of 
the bioluminescence emitted as a reflection of bacterial numbers. Student t-test 

















































Figure 5-4. ∆yapE exhibits an intracellular survival defect. . RAW264.7 
macrophages were infected with Y. pestis YPA087 (n=18) or YPA050 (n=18) at 
an MOI of 10. Bacterial numbers were determined at 10 and 24 h using a plate 
reader measuring bioluminescence. Time points were normalized to fold change 
compared to the 2 h time point by dividing each time point by the 2 h time point 











































Figure 5-5 ∆yapE does not influence invasion or adherence. RAW264.7 
macrophages were infected with Y. pestis YPA087 (n=18) or YPA050 (n=18) at 
an MOI of 10. Bacterial numbers for invasion was determined by taking 
bioluminescent readings after the bacteria was added to the macrophages (T=5 
min) and dividing by the 2 h time point after the gentamicin protection assay to 
get a percentage of intracellular bacteria compared to initial bacterial numbers. 
Adherence was determined by dividing bacteria added to the macrophages (T=5 
min) and dividing by the 20 minute time point after the cells had been washed 
twice with sterile 1X PBS. Invasion and adherence data was acquired using RLU 












































Figure 5-6 ∆pla does influence invasion but not adherence. RAW264.7 
macrophages were infected with Y. pestis YPA138 (n=18) or YPA050 (n=18) at 
an MOI of 10. Bacterial numbers for invasion was determined by taking 
bioluminescent readings after the bacteria was added to the macrophages (T=5 
min) and dividing by the 2 h time point after the gentamicin protection assay to 
get a percentage of intracellular bacteria compared to initial bacterial numbers. 
Adherence was determined by dividing bacteria added to the macrophages (T=5 
min) and dividing by the 20 minute time point after the cells had been washed 
twice with sterile 1X PBS. Invasion and adherence data was acquired using RLU 








The evaluation of the role adhesins play in the virulence of Y. pestis has been 
widely studied in how they are able to resist complement, aggregate for wider 
dissemination and their contribution to overall fitness of the bacteria. In the studies 
that have been previously outline, I explore the regulation and intracellular survival 
of the virulence factors yapE and Pla.  
While investigating how yapE is regulated, we found that many of the transposon 
insertion sites were found in sugar processing and metabolizing genes.  There was 
one insertion into a putative phage protein, where I was unable to induce the 
expression of yapE. I believe that this is because the true regulator is either 1) an 
essential gene or 2) the regulator is a sRNA that has not been annotated within the 
bacterial sequence.  After doing and extensive search of the YapE sequence 
against the published sRNAs, I was unable to find a match between the annotated 
sRNA with the promoter region of yapE. I believe that further investigation of sRNAs 
should be continued because data has shown that sRNAs have regulatory control 
over stress response such as iron depletion and sugar stress. This could be another 
reason why I was able to get a positive response when sugar transport and 
metabolism genes had transposon insertion. sRNAs are also implicated in the 
regulation of outer membrane proteins including porins and adhesins [94]. To this 
end, I recommend the following future aims to evaluate sRNAs for regulation of 
yapE: To determine how yapE is being regulated I would focus on 3 sRNAs that 
have been shown to regulate crp, hfq and Ysr170 By modulating the expression 
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levels of target genes, sRNAs can enable rapid adaptation of cellular physiology in 
response to environmental change. [148].  
Outer membrane proteins processes by pla: 
Pla has been shown to process and/or degrade outer membrane proteins and 
analysis performed by 2-DIGE and mass spectrometry showed at least 76 proteins. 
Because I only looked at the top ten proteins under the parameters of >2-fold 
increase or decrease of expression, there is a strong chance that I missed out on 
some that may have worked in concert with other proteins that may have influence 
other factors of cleavage or degradation. Future directions is to further investigate 
the proteins that were not evaluated and explore the role those proteins may play in 
the virulence of Y.pestis. 
Intracellular survival of mutations ∆ail, ∆ompA, ∆yapE and ∆pla  
When evaluating intracellular survival by the yapE mutant, there was only a slight 
attenuation observed that was statistically significant but not believed to be 
biologically relevant. This may be in part to the redundancy of other 
autotransporters and adhesins that may compensate for the lack of one of their 
expression. As stated previously, the attenuation observed in the ∆ompA strain may 
be more attributed to its inability to resist complement and targeted by PMNs early 
in infection and thereby decreasing the amount of bacteria that is being taken up by 
the macrophages. As for the pla mutation, this may also be a two-fold reason for the 
reduction of bacteria due to its primary role of being a protease. The inability to 
activate plasminogen to allow for the dissemination of the bacteria allows for fewer 
bacteria to migrate to draining lymph nodes. Moreover, as shown in previous 
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studies, Pla also degrade Yops. Intracellularly, if Yops are identified early in the 
macrophage they are able to illicit a response from the inflammasome that can 
cause the cell to enter pyroptosis effectively killing the bacteria. 
 Future direction: 
Is ∆pla attenuated intracellularly due to the inability to degrade Yops? 
To evaluate if the degradation of Yops are a fundamental cause for the survival 
defect observed in a pla mutant, I would infect macrophages with a T3SS/pla 
double mutation and compare the viability against the single pla mutant. In addition 
to an infection study to observe the intracellular survival defect, after infecting with a 
∆pla strain of Y.pestis, test for ruptured plasma membrane, and/or DNA 
fragmentation. Both signal that the cell is going under pyroptosis and a hallmark of 
inflammasome activation. 
Does double elimination of yapE and pla increase attenuation? 
To investigate attenuation intracellularly when pla and yapE are mutated, I would 
look at performing an infection using a strain that was ∆pla and ∆yapE to see if the 
attenuation is more severe than they are individually. Previous studies have shown 
when 2 or more outer membrane proteins (Ail and Pla) were mutated that there was 
significant attenuation [149]. Ail being one of the outer membrane proteins that we 
found in our 2-D/mass spec screen showed that there was a decreased in a pla 
mutant. This may show that Pla’s involvement in intracellular survival may be in 
tandem with other outer membrane proteins. When using a ∆pla and ∆yapE dual 
mutant, I would look at the reduction of bacterial attachment and uptake with 
macrophages. This may show that the processed form of YapE that is key to 
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activation for adhesion but its full form may contribute to being noticed by the cell 
that would increase its elimination by the cell. To follow up on the processing event 
of YapE, I would also investigate mutating the site Pla recognizes to cleave YapE 
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